A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic. (Q30374413)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19150474%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19150474%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

toll-like receptor

0 references

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19150474%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Yuk-Fai Lau

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19150474%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Lay-Hoon Tang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19150474%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

15 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19150474%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19150474%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19150474%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19150474%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1354-1364

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19150474%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Vaccines for seasonal and pandemic influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Reduced sensitivity of influenza A (H5N1) to oseltamivir

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Oseltamivir resistance during treatment of influenza A (H5N1) infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Innate immune recognition: mechanisms and pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Interferons, interferon-like cytokines, and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Host gene influences sensitivity to interferon action selectively for influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

A DNA transfection system for generation of influenza A virus from eight plasmids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Antigenic determinants of influenza virus hemagglutinin. XII. the epitopes of a synthetic peptide representing the C-terminus of HA1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

An overview of real-time quantitative PCR: applications to quantify cytokine gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Confirmation of H5N1 avian influenza in Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

H5N1 avian influenza: the Turkish dimension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

H5N1 Influenza Virus, Domestic Birds, Western Siberia, Russia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Efficacy of S26308 against guinea pig cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Attenuation of virus-induced airway dysfunction in rats treated with imiquimod

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Avian flu: isolation of drug-resistant H5N1 virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Expression of Toll-like receptors in cultured nasal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Activation of airway epithelial cells by toll-like receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.048

7 January 2021

based on heuristic

inferred from DOI database lookup

Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle

1 reference

https://pubmed.ncbi.nlm.nih.gov/19150474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models

1 reference

https://pubmed.ncbi.nlm.nih.gov/19150474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA

1 reference

https://pubmed.ncbi.nlm.nih.gov/19150474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/19150474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cell maturation is required for initiation of the immune response

1 reference

https://pubmed.ncbi.nlm.nih.gov/19150474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-Induced Antiviral Actions and Their Regulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19150474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Avian influenza A (H5N1) infection in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/19150474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30374413&oldid=1950304860"